RT Journal Article
SR Electronic
T1 Pitting the Gumbel and logistic growth models against one another to model COVID-19 spread
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.24.20111633
DO 10.1101/2020.05.24.20111633
A1 Yoo, Keunyoung
A1 Arashi, Mohammad
A1 Bekker, Andriette
YR 2020
UL http://medrxiv.org/content/early/2020/05/26/2020.05.24.20111633.abstract
AB In this paper, we investigate briefly the appropriateness of the widely used logistic growth curve modeling with focus on COVID-19 spread, from a data-driven perspective. Specifically, we suggest the Gumbel growth model for behaviour of COVID-19 cases in European countries in addition to the United States of America (US), for better detecting the growth and prediction. We provide a suitable fit and predict the growth of cases for some selected countries as illustration. Our contribution will stimulate the correct growth spread modeling for this pandemic outbreak.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was based upon research supported in part by the National Research Foundation (NRF) of South Africa, Reference: SRUG190308422768 grant No. 120839 and SARChI Research Chair UID: 71199, Re:IFR170227223754 grant No. 109214 and STATOMET. Opinions expressed and conclusions arrived at in this study are those of 228 the author and are not necessarily to be attributed to the NRF.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThere are a number of sources on the web that provide data on COVID-19 cases. One such site is The Humanitarian Data Exchange and one can find daily cumulative cases of COVID-19 per country. https://data.humdata.org/dataset/novel-coronavirus-2019-ncov-cases has a downloadable time_series_covid19_confirmed_global.csv starting from 2020-01-22, and for some countries, it even has the data broken down into different states or provinces. In order to perform the desired analysis, daily cases for each country had to be obtained, but some countries, such as the US and Australia, had the data broken down to state or provincial level. Since the focus of this research was per country, R open source software was used to sum along the unique values of Country, appropriately transforming the data for our analysis, then and non-linear regression was performed using the nls function. https://data.humdata.org/dataset/novel-coronavirus-2019-ncov-cases